A V Tarasov Selected Research

moexipril (Perdix)

1/2006	[Hypotensive, organoprotective, and metabolic effects of Angiotensin converting enzyme inhibitor moexipril in women with postmenopausal syndrome].
1/2006	[Comparative efficacy and safety of contemporary Angiotensin converting enzyme inhibitors moexipril and spirapril in women with postmenopausal metabolic syndrome].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A V Tarasov Research Topics

Disease

3	Hypertension (High Blood Pressure) 01/2006 - 01/2004
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2006 - 01/2006
1	Body Weight (Weight, Body) 01/2017
1	Chromosome Aberrations (Chromosome Abnormalities) 12/2009
1	Hyperinsulinism (Hyperinsulinemia) 01/2006
1	Obesity 01/2006

Drug/Important Bio-Agent (IBA)

2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2006 - 01/2006
2	moexipril (Perdix)FDA LinkGeneric 01/2006 - 01/2006
2	CholesterolIBA 01/2006 - 01/2006
2	Triglycerides (Triacylglycerol)IBA 01/2006 - 01/2006
1	Dietary Plant Proteins (Vegetable Protein)IBA 01/2017
1	Biological ProductsIBA 12/2009
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2006
1	AlbuminsIBA 01/2006
1	CarbohydratesIBA 01/2006
1	spirapril FDA Link 01/2006
1	LipidsIBA 01/2006
1	Lipoproteins (Lipoprotein)IBA 01/2006
1	LDL CholesterolIBA 01/2006
1	LeptinIBA 01/2006
1	Antihypertensive Agents (Antihypertensives)IBA 01/2004